Olit Hookalit E-Cigarettes: Fewer Puffs, More Portability

Nov.07.2024
Olit Hookalit E-Cigarettes: Fewer Puffs, More Portability
E-cigarette brand Olit recently launched the Olit Hookalit X 20000, a disposable, hookah-style e-cigarette with 22ml of 0.35% nicotine liquid. Compared to the previous model, the Olit Hookalit 40000, the new product focuses primarily on portability.

Recently, 2Firsts noted that after the Olit Hookalit 40000, e-cigarette brand Olit has launched another disposable hookah-style e-cigarette, the Olit Hookalit X 20000. According to the distributor website Vapesourcing, the product emphasizes portability and features 22ml of 0.35% nicotine liquid.

 

Olit Hookalit E-Cigarettes: Fewer Puffs, More Portability
Olit Hookalit X 20000|Image source: Olit official website

 

The following table compares the product specifications of the Olit Hookalit X 20000 with the previously released, high-puff e-cigarette product, Olit Hookalit 40000, from the same brand:

 

Olit Hookalit E-Cigarettes: Fewer Puffs, More Portability
Product Parameter Comparison | Illustration: 2Firsts

 

An article on the Ecigator website reviewing the Olit Hookalit 40000 states:

 

"With a nicotine concentration of 0.35%, the Olit Hookalit 40000 is noticeably lower than the 5% concentration commonly found in many other disposable e-cigarettes."

 

"From this perspective, the effect of vaping 40,000 puffs with the Olit Hookalit is roughly equivalent to vaping 2,857 puffs from devices like the SMOK Morf Bar, which have a nicotine concentration of 5%. This means that while the number of puffs may seem impressive, the actual nicotine delivery per puff is much lower."

 

"The large battery and sizable e-liquid tank make this device somewhat bulky compared to other products on the market, resulting in poorer portability."

 

Olit Hookalit E-Cigarettes: Fewer Puffs, More Portability
Olit Hookalit 40000 Review Article | Image source: ecigator

 

The comparison reveals that the new Olit Hookalit X 20000 has a reduced e-liquid capacity and fewer puffs, while its battery capacity has also been lowered accordingly.

 

Additionally, 2Firsts noticed that the Hookalit series of e-cigarettes from the Olit brand, which includes the Olit Hookalit X 20000, Olit Hookalit 40000, and another model, Olit Hookalit Mini, displayed on their official website, all feature a cylindrical shape and do not include the large screen designs that are currently popular on the market.

 

Olit Hookalit E-Cigarettes: Fewer Puffs, More Portability
Olit brand disposable e-cigarette products | Image source: Olit official website

 

 The new Olit Hookalit X 20000, as the "portable" product in the Hookalit series, has already been listed on the official Olit brand website and is available on distributor websites such as Vapesourcing. The product is currently marked as "COMING SOON," with a price of approximately $15.99.

 

It is worth noting that the e-cigarette brand Olit is a subsidiary of Kangor Technology, which has also recently launched a new product, the Kanger SUBOX 50000. This product features an impressive 50,000 puffs and a low nicotine concentration of 0.35%.

 

Olit Hookalit E-Cigarettes: Fewer Puffs, More Portability
Olit Trademark Registration Information | Image source: Tianyancha

 

2Firsts will continue to monitor the latest e-cigarette products and market trends globally, providing the public with accurate and authoritative industry information.

 

2Firsts' product column remains committed to delivering readers the latest product updates in the new tobacco field. We invite readers to submit insights and news on e-cigarette developments.

 

For unique perspectives or information, feel free to contact us at carrie.cai@2firsts.com or scan the QR code below.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

 NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift
NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift
According to The New York Times, Reynolds American donated $5 million to a Trump-backed super PAC shortly before the FDA introduced a new policy that could benefit major tobacco companies seeking to sell flavored vaping products.
News
May.21
Indonesian drug agency chief proposes ban on e-cigarettes and e-liquid containing harmful substances
Indonesian drug agency chief proposes ban on e-cigarettes and e-liquid containing harmful substances
Indonesian drug agency chief proposes ban on e-cigarette and e-liquid in new draft law, citing dangerous substances found.
Apr.08 by 2FIRSTS.ai
Indonesian Parliament Reviews Narcotics Law Draft, May Include Vape Ban Proposal
Indonesian Parliament Reviews Narcotics Law Draft, May Include Vape Ban Proposal
According to Beritasatu, Commission III of the Indonesian House of Representatives is reviewing the Draft Law on Narcotics and Psychotropics and considering including a proposal from the National Narcotics Agency (BNN) to ban vapes.
Apr.10 by 2FIRSTS.ai
BAT New Zealand Says Illicit Tobacco Trade Drove Nearly 29% Revenue Decline in 2025
BAT New Zealand Says Illicit Tobacco Trade Drove Nearly 29% Revenue Decline in 2025
British American Tobacco New Zealand said the illicit tobacco trade is responsible for its profit halving and revenue falling between the 2024 and 2025 financial years. Financial results filed with the Companies Office show that BAT Holdings (New Zealand) recorded 2025 revenue of NZ$180.7 million, or about US$106.95 million based on the European Central Bank’s April 27, 2026 reference rates, down from NZ$254 million, or about US$150.33 million, in 2024.
Apr.28 by 2FIRSTS.ai
Nature Health Comment Urges Wider Role for Smoke-Free Nicotine Products in Tobacco Control
Nature Health Comment Urges Wider Role for Smoke-Free Nicotine Products in Tobacco Control
Ahead of World No Tobacco Day, a Nature Health Comment by Robert Beaglehole, Ruth Bonita and Tikki Pang argues that regulated smoke-free nicotine products could help accelerate the global decline in smoking. The authors propose a “smoke-free 2040” goal and call for risk-proportionate regulation distinguishing cigarettes from lower-risk nicotine alternatives.
News
May.20
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai